Opinion: A settlement agreement between and Federal Trade commission and Express Scripts may prove more transformative than any single pricing overhaul because it has restructured the rebate-driven ...

Express Scripts has selected the first 15 technology tools to include in its new digital health formulary, which launches next month. The initial batch on the formulary—or curated list of technology- ...

Depending on which company you ask, one owes the other millions of dollars in a dispute between small drugmaker Kaleo Pharma and top pharmacy benefit manager Express Scripts. After Express Scripts ...

Express Scripts has reached a deal to acquire medical benefits management outfit eviCore healthcare in a deal that gives the pharmacy benefits manager additional heft as health giants jockey for power ...

Add Yahoo as a preferred source to see more of our stories on Google. Two dozen Democrat and Republican lawmakers have raised issues about Express Scripts, the company that oversees the U.S.

Express Scripts, soon to be under the ownership of Cigna, closed a three-year extension with Walmart on Wednesday to provide members access to the retail giant’s prescription services. The agreement ...

Kroger pharmacies are once again back in Express Scripts’ network, two years after the grocer kicked the massive pharmacy benefit manager to the curb over its allegedly unsustainable pricing model.

Pharmacy benefit manager Express Scripts ESRX announced that it will include two new cholesterol-lowering drugs – Regeneron/Sanofi’s REGN/SNY Praluent and Amgen’s AMGN Repatha – on its National ...

Express Scripts is putting companies offering cutting-edge treatments into a "formulary" of recommendations for insurance plans and doctors. The hope is to make it easier for digital health companies ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Express Scripts sees a booming market in processing pet prescriptions ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...